Letter to editor: Intradiscal steroid injection for lumbar canal stenosis: novel but not yet ready for clinical adoption Authors: Gauri Khurana, Varun Singla, Babita Ghai Published: 2025 To the Editor, We read with interest the article by Kim et al. [1], “Effectiveness of intradiscal steroid injection for spinal stenosis: a retrospective cohort study in South Korea.” While the topic is clinically relevant, several methodological and interpretive issues warrant clarification. Study design and reporting This retrospective analysis constitutes level III evidence and should not be interpreted as conclusive. Only univariable comparisons were presented; a multivariable approach incorporating laterality, Modic changes, Pfirrmann grade, and comorbidities could better predict surgical conversion. Technique-related concerns Performing intradiscal steroid injection (ISI) in the lateral position rather than prone raises concerns about fluoroscopic reproducibility. Furthermore, mixing ropivacaine with dexamethasone is chemically incompatible, yet this combination was used without justification [2]. The description of provocative discography lacked essential details (contrast volume, injection pressure), which are critical per standardized guidelines [3,4]. Reporting of epidural spread, necessary to confirm intradiscal localization, was absent. Clinical outcomes Pain relief was assessed up to 6 weeks, but no longer-term outcomes or magnetic resonance imaging follow-up were provided to evaluate potential disc degeneration. Although histologic safety data were cited, imaging confirmation within the study cohort is lacking. Moreover, details regarding concurrent conservative treatments (physiotherapy, analgesics, neuropathic agents) and whether they were standardized between groups were not described. Statistical considerations Repeated measures of pain scores were analyzed without accounting for intra-patient correlation. Repeated-measures analysis of variance with Bonferroni correction, or nonparametric alternatives, would have been more appropriate. The interval to surgical conversion beyond 6 weeks also requires clarification. Safety and complications Though no subdural injections were reported, the verification method was not described. Explicit reporting of infection surveillance is essential for safety interpretation. Interpretation and context Recent systematic reviews suggest that intradiscal glucocorticoid injections may provide significant short-term pain and functional improvement, but these benefits diminish beyond 3–6 months [5]. Similarly, meta-analyses of epidural steroid injections for lumbar disc herniation and stenosis confirm only short-term relief, with little durable effect [6,7]. These findings reinforce the need for cautious interpretation of uncontrolled retrospective data. Without standardized technique, prespecified surgical criteria, validated functional outcomes, comparator groups (such as epidural steroid injection), and comprehensive complication monitoring, definitive conclusions regarding ISI in lumbar canal stenosis remain premature. Prospective controlled studies with imaging follow-up are essential before ISI can be considered a viable treatment alternative. Footnotes Conflict of Interest No potential conflict of interest relevant to this article was reported. Author Contributions All the work for the preparation of this letter was done by all authors. References